During Sleep Health Week from August 11 to 15, 2025, Australians struggling with insomnia have a reason to feel hopeful. A significant clinical trial is underway, focusing on a new CBD treatment for insomnia. This study is actively seeking participants across various Australian cities.
The trial, led by Avecho Biotechnology Limited, aims to discover how effective their CBD product is in treating insomnia. They are looking to recruit over 500 patients in cities like Melbourne, Sydney, Gold Coast, and Perth. Participants will take Avecho’s soft-gel capsules containing either 75 mg or 150 mg of CBD or a placebo for eight weeks.
What is CBD? Cannabidiol (CBD) is a natural compound derived from the cannabis plant. It’s been recognized for its potential in treating various health issues, such as epilepsy, anxiety, and now, insomnia. Unlike its psychoactive cousin THC, CBD doesn’t produce a “high.”
Experts in the field see the potential here. Dr. Paul Gavin, CEO of Avecho, mentions that this trial is a chance for those battling insomnia to access a novel treatment. He highlights the importance of collaboration with clinical specialists across Australia to ensure robust results.
The statistics around insomnia are alarming. Globally, about 10-30% of people experience insomnia, with 10-15% suffering from chronic insomnia. In Australia, nearly 60% report symptoms, which costs the economy an estimated $19.1 billion annually due to lost productivity and other factors, according to research by the Sleep Health Foundation.
Interestingly, since a key policy change by the Australian Therapeutics Goods Administration (TGA) in 2020, CBD products can now be sold over the counter. This makes it easier for individuals to access therapeutic options without navigating complex regulations. New Zealand has also adopted a similar policy, reflecting a broader trend towards acceptance of CBD in the region.
As more people express interest in exploring CBD for insomnia, social media discussions are heating up. Hashtags related to sleep health and CBD treatments are trending, revealing a growing community eager to share experiences and tips.
In short, the upcoming clinical trial presents a pivotal moment for those affected by insomnia. With the support of advanced research and changing regulations, the path to better sleep may soon be within reach for many.
For more information, check out the ongoing trial details at Avecho.
Source link
MELBOURNE, Australia, clinical trial, Avecho Biotechnology Limited, patient recruitment, Australia, Sydney, CBD products, insomnia
